New CEO Brett Monia Takes The Lead As Ionis Prioritizes Non-Partnered Programs
Executive Summary
Monia told Scrip at the J.P. Morgan Healthcare Conference that the company will be more selective about partnerships going forward and build commercial capabilities to market Ionis-owned drugs.